Implantable Antenna–Biosensor Systems for Cancer Surveillance: Evidence, Biological Interfaces, and a Translational Design Framework
An implanted antenna can support cancer surveillance when a disease-related change produces a reproducible measurement that can be distinguished from relevant benign changes and interpreted within a defined clinical pathway. This critical review connects cancer biomarkers, local physiological changes, biosensor mechanisms, and in-body RF interfaces across major tumour sites, with particular attention to oral, head and neck, and lung cancer. Three approaches are distinguished: antennas that sense tissue dielectric properties, chemically functionalized antenna immunosensors, and separate cancer sensors coupled to implanted radio telemetry. The unresolved problem is durable, site- and endpoint-specific surveillance under realistic sampling, inflammatory, biointerface, and wireless constraints. Comparative evidence tables identify measured specimens, demonstrated endpoints, candidate sensor–antenna combinations, and decisive missing experiments. A compact quantitative framework links target access, binding, RF observability, confounder control, read availability, and false-alert burden. A gated development workflow, illustrated using a published CEA antenna, converts these constraints into testable research requirements. The outcome is a research roadmap for clinically interpretable local warnings.
Authors
- Sumer Singh Singhwal (ORCID: https://orcid.org/0000-0002-8065-3284)
Institutions
- Politecnico di Torino (IT)
Publication Details
- Journal
- Electronics
- Published
- 2026-11-19
- DOI
- https://doi.org/10.3390/electronics15225395
- Primary Topic
- Wireless Body Area Networks
- Type
- article
- Field-Weighted Citation Impact
- 0.00